The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome
Primary Sjögren's syndrome (pSjS) is a chronic autoimmune disease that causes dry eye and mouth. No laboratory parameters to monitor the activation of this disease have been identified. Therefore, any possible relationships between salivary and blood myxovirus resistance 1 (MX1) and pSjS must b...
Gespeichert in:
| Veröffentlicht in: | Clinics (São Paulo, Brazil) Brazil), 2019, Vol.74, p.e631-e631, Article e631 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e631 |
|---|---|
| container_issue | |
| container_start_page | e631 |
| container_title | Clinics (São Paulo, Brazil) |
| container_volume | 74 |
| creator | Aydemir, Yasemin Gul Kocakusak, Ahmet |
| description | Primary Sjögren's syndrome (pSjS) is a chronic autoimmune disease that causes dry eye and mouth. No laboratory parameters to monitor the activation of this disease have been identified. Therefore, any possible relationships between salivary and blood myxovirus resistance 1 (MX1) and pSjS must be prospectively studied.
Thirty female patients with pSjS, 30 women with rheumatoid arthritis (RA) without secondary Sjögren's syndrome (SjS) and 28 healthy control women were enrolled in this investigation. Analyses of MX1 by the enzyme-linked immunosorbent assay (ELISA) method, SS-A (Ro) and SS-B (La) tests by the strip immunoblot method, anti-nuclear antibody (ANA) tests by immunofluorescence and the measurement of serum rheumatoid factor (RF), C3, C4, immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) were performed.
The serum level of MX1 in patients without Raynaud phenomenon was higher than in those with Raynaud phenomenon (p:0.029, p |
| doi_str_mv | 10.6061/clinics/2019/e631 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_scielo_journals_S1807_59322019000100237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1807_59322019000100237</scielo_id><els_id>S1807593222006275</els_id><doaj_id>oai_doaj_org_article_b099eb1fbfc44e1090781a5d5d743655</doaj_id><sourcerecordid>2250620411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-eabcae9b5ba915b075d5b97ad9f121a73b381e5e7842ec0bdb02de05d386ac933</originalsourceid><addsrcrecordid>eNp9Ut1qFDEUHkSxtfoA3kju9Ga7-ZnMTBCEUqwWKoKt1yE_Z7ZZZpI1ySzuA_hKfQFfzEx3LfZGCCScc77vfDnnq6rXBJ82uCFLMzjvTFpSTMQSGkaeVMdEdHjBGaVPy7vD7YILRo-qFymtMWaC1fx5dcQIrUnTkOPq180tINiqYVLZBY9Cj3KJfNn9DFsXp4S-QXIpK28AEbSJIYPzqJwEcRqR8hYlNbitQjmgMXiXQ0TWJVAJkDK5ZO55C2IT3ajiDl2vf9-tIvi3CaWdtzGM8LJ61qshwavDfVJ9v_h4c_55cfX10-X52dXC1F2TF6C0USA010oQrnHLLdeiVVb0hBLVMs06AhzarqZgsLYaUwuYW9Y1ygjGTqrLPa8Nai0PgmRQTt4HQlxJFbMzA0iNhQBNet2bugaCBW47okpD29as4bxwne65knEwBLkOU_RFvLyexy7nsc97wRgTjClrC-DDHrCZ9AjWgM9RDY9UPM54dytXYStLt06IueO7A0EMPyZIWY4uGRgG5SFMSVLKcUNxTUgpJftSE0NKEfqHNgTL2Tvy4B05a5Szdwrmzb_6HhB_zVIK3u8LoKxo6yDK-evFGdZFMLnM0P2H_g_-V9he</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2250620411</pqid></control><display><type>article</type><title>The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Aydemir, Yasemin Gul ; Kocakusak, Ahmet</creator><creatorcontrib>Aydemir, Yasemin Gul ; Kocakusak, Ahmet</creatorcontrib><description>Primary Sjögren's syndrome (pSjS) is a chronic autoimmune disease that causes dry eye and mouth. No laboratory parameters to monitor the activation of this disease have been identified. Therefore, any possible relationships between salivary and blood myxovirus resistance 1 (MX1) and pSjS must be prospectively studied.
Thirty female patients with pSjS, 30 women with rheumatoid arthritis (RA) without secondary Sjögren's syndrome (SjS) and 28 healthy control women were enrolled in this investigation. Analyses of MX1 by the enzyme-linked immunosorbent assay (ELISA) method, SS-A (Ro) and SS-B (La) tests by the strip immunoblot method, anti-nuclear antibody (ANA) tests by immunofluorescence and the measurement of serum rheumatoid factor (RF), C3, C4, immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) were performed.
The serum level of MX1 in patients without Raynaud phenomenon was higher than in those with Raynaud phenomenon (p:0.029, p<0.05, statistically significant). There was a statistically significant positive association between hemoglobin levels and MX1 serum levels. No statistically significant association was found among the other parameters. Low MX1 levels were shown to be associated with both a low disease activity score based on the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) and hydroxychloroquine use in all patients.
MX1 levels have a considerable impact on the assessment of the disease activity in SjS. We believe that more-comprehensive studies should be performed on patients with pSjS who do not use hydroxychloroquine to prove this relationship and that MX1 levels should be used as a routine marker for the assessment of pSjS disease activity. Further studies are needed to create awareness of the role that MX1 has in the diagnosis of pSjS, which may help to uncover novel pathways for new therapeutic modalities.</description><identifier>ISSN: 1807-5932</identifier><identifier>ISSN: 1980-5322</identifier><identifier>EISSN: 1980-5322</identifier><identifier>DOI: 10.6061/clinics/2019/e631</identifier><identifier>PMID: 31241661</identifier><language>eng</language><publisher>Brazil: Elsevier España, S.L.U</publisher><subject>Adult ; Antibodies, Antinuclear - blood ; Biomarkers - analysis ; Enzyme-Linked Immunosorbent Assay ; ESSDAI ; Female ; Humans ; Hydroxychloroquine ; Immunoglobulin A - blood ; Immunoglobulin G - blood ; Immunoglobulin Isotypes - blood ; Immunoglobulin M - blood ; MEDICINE, GENERAL & INTERNAL ; Middle Aged ; Myxovirus Resistance 1 ; Myxovirus Resistance Proteins - immunology ; Original ; Saliva - chemistry ; Sjogren's Syndrome - diagnosis ; Sjogren's Syndrome - immunology ; Sjogren's Syndrome - metabolism ; Sjögren's syndrome</subject><ispartof>Clinics (São Paulo, Brazil), 2019, Vol.74, p.e631-e631, Article e631</ispartof><rights>2019 CLINICS</rights><rights>Copyright © 2019 CLINICS 2019</rights><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-eabcae9b5ba915b075d5b97ad9f121a73b381e5e7842ec0bdb02de05d386ac933</citedby><cites>FETCH-LOGICAL-c486t-eabcae9b5ba915b075d5b97ad9f121a73b381e5e7842ec0bdb02de05d386ac933</cites><orcidid>0000-0001-9685-6660 ; 0000-0002-8421-7287</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558995/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558995/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,4025,27928,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31241661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aydemir, Yasemin Gul</creatorcontrib><creatorcontrib>Kocakusak, Ahmet</creatorcontrib><title>The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome</title><title>Clinics (São Paulo, Brazil)</title><addtitle>Clinics (Sao Paulo)</addtitle><description>Primary Sjögren's syndrome (pSjS) is a chronic autoimmune disease that causes dry eye and mouth. No laboratory parameters to monitor the activation of this disease have been identified. Therefore, any possible relationships between salivary and blood myxovirus resistance 1 (MX1) and pSjS must be prospectively studied.
Thirty female patients with pSjS, 30 women with rheumatoid arthritis (RA) without secondary Sjögren's syndrome (SjS) and 28 healthy control women were enrolled in this investigation. Analyses of MX1 by the enzyme-linked immunosorbent assay (ELISA) method, SS-A (Ro) and SS-B (La) tests by the strip immunoblot method, anti-nuclear antibody (ANA) tests by immunofluorescence and the measurement of serum rheumatoid factor (RF), C3, C4, immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) were performed.
The serum level of MX1 in patients without Raynaud phenomenon was higher than in those with Raynaud phenomenon (p:0.029, p<0.05, statistically significant). There was a statistically significant positive association between hemoglobin levels and MX1 serum levels. No statistically significant association was found among the other parameters. Low MX1 levels were shown to be associated with both a low disease activity score based on the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) and hydroxychloroquine use in all patients.
MX1 levels have a considerable impact on the assessment of the disease activity in SjS. We believe that more-comprehensive studies should be performed on patients with pSjS who do not use hydroxychloroquine to prove this relationship and that MX1 levels should be used as a routine marker for the assessment of pSjS disease activity. Further studies are needed to create awareness of the role that MX1 has in the diagnosis of pSjS, which may help to uncover novel pathways for new therapeutic modalities.</description><subject>Adult</subject><subject>Antibodies, Antinuclear - blood</subject><subject>Biomarkers - analysis</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>ESSDAI</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxychloroquine</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin Isotypes - blood</subject><subject>Immunoglobulin M - blood</subject><subject>MEDICINE, GENERAL & INTERNAL</subject><subject>Middle Aged</subject><subject>Myxovirus Resistance 1</subject><subject>Myxovirus Resistance Proteins - immunology</subject><subject>Original</subject><subject>Saliva - chemistry</subject><subject>Sjogren's Syndrome - diagnosis</subject><subject>Sjogren's Syndrome - immunology</subject><subject>Sjogren's Syndrome - metabolism</subject><subject>Sjögren's syndrome</subject><issn>1807-5932</issn><issn>1980-5322</issn><issn>1980-5322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9Ut1qFDEUHkSxtfoA3kju9Ga7-ZnMTBCEUqwWKoKt1yE_Z7ZZZpI1ySzuA_hKfQFfzEx3LfZGCCScc77vfDnnq6rXBJ82uCFLMzjvTFpSTMQSGkaeVMdEdHjBGaVPy7vD7YILRo-qFymtMWaC1fx5dcQIrUnTkOPq180tINiqYVLZBY9Cj3KJfNn9DFsXp4S-QXIpK28AEbSJIYPzqJwEcRqR8hYlNbitQjmgMXiXQ0TWJVAJkDK5ZO55C2IT3ajiDl2vf9-tIvi3CaWdtzGM8LJ61qshwavDfVJ9v_h4c_55cfX10-X52dXC1F2TF6C0USA010oQrnHLLdeiVVb0hBLVMs06AhzarqZgsLYaUwuYW9Y1ygjGTqrLPa8Nai0PgmRQTt4HQlxJFbMzA0iNhQBNet2bugaCBW47okpD29as4bxwne65knEwBLkOU_RFvLyexy7nsc97wRgTjClrC-DDHrCZ9AjWgM9RDY9UPM54dytXYStLt06IueO7A0EMPyZIWY4uGRgG5SFMSVLKcUNxTUgpJftSE0NKEfqHNgTL2Tvy4B05a5Szdwrmzb_6HhB_zVIK3u8LoKxo6yDK-evFGdZFMLnM0P2H_g_-V9he</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Aydemir, Yasemin Gul</creator><creator>Kocakusak, Ahmet</creator><general>Elsevier España, S.L.U</general><general>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</general><general>Faculdade de Medicina / USP</general><general>Elsevier España</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>GPN</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9685-6660</orcidid><orcidid>https://orcid.org/0000-0002-8421-7287</orcidid></search><sort><creationdate>2019</creationdate><title>The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome</title><author>Aydemir, Yasemin Gul ; Kocakusak, Ahmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-eabcae9b5ba915b075d5b97ad9f121a73b381e5e7842ec0bdb02de05d386ac933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Antibodies, Antinuclear - blood</topic><topic>Biomarkers - analysis</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>ESSDAI</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxychloroquine</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin Isotypes - blood</topic><topic>Immunoglobulin M - blood</topic><topic>MEDICINE, GENERAL & INTERNAL</topic><topic>Middle Aged</topic><topic>Myxovirus Resistance 1</topic><topic>Myxovirus Resistance Proteins - immunology</topic><topic>Original</topic><topic>Saliva - chemistry</topic><topic>Sjogren's Syndrome - diagnosis</topic><topic>Sjogren's Syndrome - immunology</topic><topic>Sjogren's Syndrome - metabolism</topic><topic>Sjögren's syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aydemir, Yasemin Gul</creatorcontrib><creatorcontrib>Kocakusak, Ahmet</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinics (São Paulo, Brazil)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aydemir, Yasemin Gul</au><au>Kocakusak, Ahmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome</atitle><jtitle>Clinics (São Paulo, Brazil)</jtitle><addtitle>Clinics (Sao Paulo)</addtitle><date>2019</date><risdate>2019</risdate><volume>74</volume><spage>e631</spage><epage>e631</epage><pages>e631-e631</pages><artnum>e631</artnum><issn>1807-5932</issn><issn>1980-5322</issn><eissn>1980-5322</eissn><abstract>Primary Sjögren's syndrome (pSjS) is a chronic autoimmune disease that causes dry eye and mouth. No laboratory parameters to monitor the activation of this disease have been identified. Therefore, any possible relationships between salivary and blood myxovirus resistance 1 (MX1) and pSjS must be prospectively studied.
Thirty female patients with pSjS, 30 women with rheumatoid arthritis (RA) without secondary Sjögren's syndrome (SjS) and 28 healthy control women were enrolled in this investigation. Analyses of MX1 by the enzyme-linked immunosorbent assay (ELISA) method, SS-A (Ro) and SS-B (La) tests by the strip immunoblot method, anti-nuclear antibody (ANA) tests by immunofluorescence and the measurement of serum rheumatoid factor (RF), C3, C4, immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) were performed.
The serum level of MX1 in patients without Raynaud phenomenon was higher than in those with Raynaud phenomenon (p:0.029, p<0.05, statistically significant). There was a statistically significant positive association between hemoglobin levels and MX1 serum levels. No statistically significant association was found among the other parameters. Low MX1 levels were shown to be associated with both a low disease activity score based on the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) and hydroxychloroquine use in all patients.
MX1 levels have a considerable impact on the assessment of the disease activity in SjS. We believe that more-comprehensive studies should be performed on patients with pSjS who do not use hydroxychloroquine to prove this relationship and that MX1 levels should be used as a routine marker for the assessment of pSjS disease activity. Further studies are needed to create awareness of the role that MX1 has in the diagnosis of pSjS, which may help to uncover novel pathways for new therapeutic modalities.</abstract><cop>Brazil</cop><pub>Elsevier España, S.L.U</pub><pmid>31241661</pmid><doi>10.6061/clinics/2019/e631</doi><orcidid>https://orcid.org/0000-0001-9685-6660</orcidid><orcidid>https://orcid.org/0000-0002-8421-7287</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1807-5932 |
| ispartof | Clinics (São Paulo, Brazil), 2019, Vol.74, p.e631-e631, Article e631 |
| issn | 1807-5932 1980-5322 1980-5322 |
| language | eng |
| recordid | cdi_scielo_journals_S1807_59322019000100237 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Adult Antibodies, Antinuclear - blood Biomarkers - analysis Enzyme-Linked Immunosorbent Assay ESSDAI Female Humans Hydroxychloroquine Immunoglobulin A - blood Immunoglobulin G - blood Immunoglobulin Isotypes - blood Immunoglobulin M - blood MEDICINE, GENERAL & INTERNAL Middle Aged Myxovirus Resistance 1 Myxovirus Resistance Proteins - immunology Original Saliva - chemistry Sjogren's Syndrome - diagnosis Sjogren's Syndrome - immunology Sjogren's Syndrome - metabolism Sjögren's syndrome |
| title | The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T01%3A41%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evaluation%20of%20the%20Myxovirus%20Resistance%201%20protein%20in%20serum%20and%20saliva%20to%20monitor%20disease%20activation%20in%20primary%20Sj%C3%B6gren's%20syndrome&rft.jtitle=Clinics%20(S%C3%A3o%20Paulo,%20Brazil)&rft.au=Aydemir,%20Yasemin%20Gul&rft.date=2019&rft.volume=74&rft.spage=e631&rft.epage=e631&rft.pages=e631-e631&rft.artnum=e631&rft.issn=1807-5932&rft.eissn=1980-5322&rft_id=info:doi/10.6061/clinics/2019/e631&rft_dat=%3Cproquest_doaj_%3E2250620411%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2250620411&rft_id=info:pmid/31241661&rft_scielo_id=S1807_59322019000100237&rft_els_id=S1807593222006275&rft_doaj_id=oai_doaj_org_article_b099eb1fbfc44e1090781a5d5d743655&rfr_iscdi=true |